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Ureaplasma urealyticum: Is it a Cause of Chronic 
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E.E.L. Wang. The Hospital for Sick Children, U n i w i t y  of %onto, 
Toronto, Ontario, Canada 
Background U urealyticum has been implicated in fetal loss, 
chorioamnionitis, prematurity, and neonatal pneumonia and menin- 
gitis. Studies of its association with CLD have been contradictory. 
Objective: Tlus review was performed to summarize results of all 
controlled s tud~es  addressing the relationship. 
Methods: Studies were sought using Medline and a hand search 
of abstracts fiom SPR, ESPR, and ICAAC. Three investigators in- 
dependently reviewed each study's quality. The relative risk (RR) 
for each study was calculated as the kquency of CLD amongst col- 
onized infantslthe kequency of CLD in non colonized infants. A 
pooled RR estimate was determined. 
Ftesults: 17 studies were included; 13 were complete manuscripts, 
4 were abstracts. 16 were cohort studies, one was a case control study. 
RR was >1.0 in all studies. The pooled estimate was 1.75 (95% 
confidence interval, 1.53-1.99). The M in studies conducted after 
availability of surfactant (RR 1.24) was signdicantly lower than that 
in older studies (RR 1.92). Other features, complete manuscript vs. 
abstract, bnthweight restriction, site of specimen did not sigdicantly 
change the conclusion. 
Conclusion: There appears to be an association between U UR- 
alyticum colonization and CLD. Whether this association is causative 
needs to be determined through a randomized controlled trial. 
(s30( Procalcitonin: A Marker for Neonatal Sepsis 
D. Gendrel, C. Bohuon. Hop Saint Vincenf de Paul, Paris, G IGR, 
K&juij Franre 
Procalcitonin (F'CT), the propeptide of calcitonin increases dramat- 
ically during severe bacterial sepsis and after endotoxin injection, 
while serum PCT remains low in vkal diseases. PCT allows clearly 
the dstinction between bacterial and viral meningitis in children. 
PCT is low in normal neonates with a slight increase during the 
second or thud day of life. In neonates with an invasive bacterial 
mfection (positive blood or CSF culture) PCT at adrmssion in the 
neonatal unit was always high (5-100 pgfl) and more discriminant 
than initial CRF' levels. In neonates with a viral infection or 
with bacterial colonization without invasive infection, PCT was 
always low and allowed diagnosis with bacterial sepsis. Our first 
comparative results show that pCT is more discriminant than IL6 
or IL8 which were found low in mfected children and high in 
non-infected neonates with neonatal distress. The situation of 
neonates with multiorgan failure or severe hypaxemia must be 
explored because we have found in these patients high PCT levels 
without infection. PCT appears to be an early and sensitive marker 
of bacterial neonatal sepsis. 
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Background Congenital infection with Toxoplatma gondii can lead 
congenital toxoplasmosis 
E Forestier *. ' Centre Hospitalier 
to serious sequellae. The purpose of this study is to show the risks of 
toxoplasmosis during pregnancy and the results of PCR in amniotic 
fluid for the prenatal diagnosis of congenital toxoplasmosis. 
Methods: Prenatal diagnosis includmg ultrasonography, amnio- 
centesis and fetal blood sampling was performed in 2631 cases of 
acquired maternal Toxoplasma gondii infection during pregnancy. In 
339 consecutive cases, competitive polymerase chain reaction (using 
an internal control) performed on amniotic fluid was prospectively 
studied and compared to the classical diagnostic methods. Fetal blood 
sampling was then abandoned and the prenatal diagnosis relies on 
amniocentesis alone. 
Results: There seems to be little or no risk for maternal infec- 
tions acquired during the two weeks following the last menstruation 
period. After this period, the, the risk of fetal mfection rises steadily 
with gestational age at the. In the 339 cases where DNA amplifica- 
tion was studied, congenital infection was demonstrated in 34 fetuses 
by conventional methods and polymerase chain reaction was positive 
in all cases. In 3 additional cases, polymerase chain reaction was the 
only positive test and corresponded to active fetal disease. One false 
negative result occurred but no false positive result was observed. 
Polymerase chain reaction performs better than classical parasitologi- 
cal methods (sensitivity: 97.4 versus 89.5 percent; negative predictive 
value: 99.7 versus 98.7 percent). With an experience relying now on 
more than 2000 prenatal diagnoses, these figures can be confirmed 
with no fake positive diagnosis and an incidence of false negative 
results of around 1%. 
Conclusions: Fetal blood sampling is definitely not necessary 
since amniocentesis with polymerase chain reaction (carefully per- 
formed in order to prevent false positive and to detect false negative 
results) provide a safer means to obtain dugnostic information within 
one day of sampling. 
Maternal-Fetal CMV Infection: From Diagnosis to 
Therapy 
G. N i p .  Pediab and Obst. Inrt., "La Sapienza" Univ., Rome, h f y  
Cytomegalovirus (CMV) is the most common and serious con- 
genital infection, following both primary and, less ftequently, re- 
current infection in pregnancy. Active CMV infection occun in 
3 to 6% of pregnant women and 0.5 to 2.5% of neonates Symp- 
tomatic congenital CMV infection includes signs of reticuloendothe- 
lial (hepatosplenomegaly jaundce, thrombocytopenia) and neuro- 
logic (seizures, microcephaly, periventriculat calcifications, hydro- 
cephalus, migrational disorders) involvement, ocular manifestations 
(chorioretkitis, microphtalmia, cataract), sensorineural hearing loss, 
pneumonia and purpura. Gestational screening includes detection of 
CMV IgM and IgG antibodies: when active infection is suspected, 
CMV DNA should be detected by PCR in blood, urine and cervical 
samples. CMV IgG avidity test is a useful tool for differentiating pri- 
mary fiom recurrent mfections. Prenatal diagnosis of CMV infection 
may be obtained by viral isolation or CMV DNA detection in the 
amniotic fluid. Congenital CMV infection is shown by viral isolation 
or CMV DNA detection in urine or blood. Serologic investigations 
can be useful, but CMV IgM antibodies are not fkquently detected 
and the neonate's levels of IgG antibodies may not be higher than 
those of the mother. Maternal-fetal CMV infection is confirmed by 
the persistence of CMV IgG in the idant. Neurologic involvement 
may be revealed by detection of CMV DNA or antibodies in the 
cerebrospinal fluid. Infants with severe CMV &ease can be treated 
with ganciclovir or foscarnet. Primary maternal infection could be 
treated with intravenous and intra-amniotic CMV immunoglobulins. 
